Background: Tick-borne encephalitis (TBE) is increasing in Europe. We aimed to evaluate the immunogenicity and safety of TBE-vaccination.
Methods: This systematic review was registered at PROSPERO (#CRD42020155737) and conducted in accordance with PRISMA guidelines.